Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Performance Evaluation of the VitaSIRO Solo™ SARS-CoV-2/Flu/RSV Assay

NCT06689423 is registered in ClinicalTrials.gov with Credo Diagnostics Biomedical Pte. Ltd. as lead sponsor.

NCT NCT06689423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06689423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Performance Evaluation of the VitaSIRO Solo™ SARS-CoV-2/Flu/RSV Assay
Lead sponsor
Credo Diagnostics Biomedical Pte. Ltd.
Phase
Observational
Overall status
Completed
Start date
November 1, 2024
Completion date
December 18, 2025
Enrollment
1,268 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza, rsv, sars-cov-2